Zobrazeno 1 - 9
of 9
pro vyhledávání: '"O J L Loosveld"'
Autor:
J. L. van Dam, E. M. M. Verkolf, E. N. Dekker, B. A. Bonsing, S. O. Bratlie, L. A. A. Brosens, O. R. Busch, L. M. J. W. van Driel, C. H. J. van Eijck, S. Feshtali, P. Ghorbani, D. J. A. de Groot, J. W. B. de Groot, B. C. M. Haberkorn, I. H. de Hingh, B. van der Holt, T. M. Karsten, M. B. van der Kolk, K. J. Labori, M. S. L. Liem, O. J. L. Loosveld, I. Q. Molenaar, M. B. Polée, H. C. van Santvoort, J. de Vos – Geelen, M. L. Wumkes, G. van Tienhoven, M. Y. V. Homs, M. G. Besselink, J. W. Wilmink, B. Groot Koerkamp, for the Dutch Pancreatic Cancer Group
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Surgical resection followed by adjuvant mFOLFIRINOX (5-fluorouracil with leucovorin, irinotecan, and oxaliplatin) is currently the standard of care for patients with resectable pancreatic cancer. The main concern regarding adjuvan
Externí odkaz:
https://doaj.org/article/9bd0b84a5c244ba18797a99563ce5af4
Autor:
Q. P. Janssen, J. L. van Dam, B. A. Bonsing, H. Bos, K. P. Bosscha, P. P. L. O. Coene, C. H. J. van Eijck, I. H. J. T. de Hingh, T. M. Karsten, M. B. van der Kolk, G. A. Patijn, M. S. L. Liem, H. C. van Santvoort, O. J. L. Loosveld, J. de Vos-Geelen, B. M. Zonderhuis, M. Y. V. Homs, G. van Tienhoven, M. G. Besselink, J. W. Wilmink, B. Groot Koerkamp, for the Dutch Pancreatic Cancer Group
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Neoadjuvant therapy has several potential advantages over upfront surgery in patients with localized pancreatic cancer; more patients receive systemic treatment, fewer patients undergo futile surgery, and R0 resection rates are hi
Externí odkaz:
https://doaj.org/article/c4666a70be2f4516b363089ddb9e6b2b
Autor:
Jean H. G. Klinkenbijl, Laurents P. S. Stassen, F.C. den Boer, Mhw Frings-Dresen, Kristien M. A. J. Tytgat, R. P. Veenstra, P. van Duijvendijk, AnneClaire G. N. M. Zaman, Patrick H. J. Hemmer, Harm J. T. Rutten, M. M. Mok, L. C. M. Dol, J. C. Brinkhuis, A. G. E. M. de Boer, David J. Bruinvels, Menno A. Brink, A. Schoorlemmer, E. R. Velzing, Bas Lamme, A. W. H. van de Ven, D. J. A. Sonneveld, T. Rejda, O. J. L. Loosveld
Publikováno v:
Journal of Occupational Rehabilitation, 31, 323-338. SPRINGER/PLENUM PUBLISHERS
Journal of occupational rehabilitation, 31(2), 323-338. Springer New York
Journal of Occupational Rehabilitation, 31(2), 323-338. Springer
Journal of Occupational Rehabilitation
Journal of occupational rehabilitation, 31(2), 323-338. Springer New York
Journal of Occupational Rehabilitation, 31(2), 323-338. Springer
Journal of Occupational Rehabilitation
Purpose The aim of this research was to study the effectiveness on return to work (RTW) of an early tailored work-related support intervention in patients diagnosed with curative gastrointestinal cancer. Methods A multicenter randomized controlled tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6de7df6d044d8ea4cc8a949685a0661
https://research.rug.nl/en/publications/5f48b603-4ee8-4a37-bfaa-ce2208b20af6
https://research.rug.nl/en/publications/5f48b603-4ee8-4a37-bfaa-ce2208b20af6
Autor:
S L, Smit, T M A, Peters, I A M, Gisbertz, W, Moolenaar, Y, Hendriks, H H, Vincent, D, Houtsma, O J L, Loosveld, A E, van Herwaarden, A J M, Rennings, D W, Swinkels
Publikováno v:
The Netherlands journal of medicine. 76(8)
Background: Type 2A hereditary haemochromatosis (type 2A HH) is a rare iron-loading disorder caused by mutations in the HFE2 gene, which encodes the HJV protein. We present characteristics, treatment and follow-up of subjects diagnosed with type 2A H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::40209f7e739c6190ae7673f0ad8607a0
https://pubmed.ncbi.nlm.nih.gov/30362946
https://pubmed.ncbi.nlm.nih.gov/30362946
Autor:
I. H. J. T. de Hingh, S.H. Goey, O. J. L. Loosveld, G.J.M. Creemers, F.N. van Erning, Valery E.P.P. Lemmens
Publikováno v:
Annals of Oncology, 24(11), 2839-2844. Elsevier Ltd.
Little is known about the effects of adjuvant chemotherapy on the risk of distant recurrence in elderly with stage III colon cancer, treated in daily practice.One thousand two hundred and ninety-one stage III colon cancer patients diagnosed in the so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8091c0b4b8a4bfc508cd5ba8e7661f66
https://pure.eur.nl/en/publications/de6537bd-6530-48df-afab-330c76de1627
https://pure.eur.nl/en/publications/de6537bd-6530-48df-afab-330c76de1627
Autor:
G.J.M. Creemers, O. J. L. Loosveld, I.H.J.T. de Hingh, Valery E.P.P. Lemmens, Lieke G.E.M. Razenberg, Y.R.B.M. van Gestel, Laurens V. Beerepoot, Gerard Vreugdenhil
Publikováno v:
BMC Cancer, 16. BioMed Central Ltd.
BMC Cancer, 16:110, 1-9. BioMed Central Ltd
BMC Cancer
BMC Cancer, 16:110, 1-9. BioMed Central Ltd
BMC Cancer
Background: Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in daily practice. Since the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::453620396a963c890210b283db77ed94
https://pure.eur.nl/en/publications/4dda758f-41d2-4afe-af1d-04b760e9a372
https://pure.eur.nl/en/publications/4dda758f-41d2-4afe-af1d-04b760e9a372
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 29:310-313
Measurement of thyroid stimulating immunoglobulins (TSI) has not yet found widespread application in the diagnosis and management of Graves' disease. One of the problems is the poor and variable sensitivity of the different assays. We therefore studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e81723e7c4200c0cf79372169fc5de4
https://doi.org/10.1177/000456329202900311
https://doi.org/10.1177/000456329202900311
Publikováno v:
The Netherlands journal of medicine. 65(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fe5807fb45094d1637b095dddf8fcb9
https://pubmed.ncbi.nlm.nih.gov/17587650
https://pubmed.ncbi.nlm.nih.gov/17587650
Autor:
S.H. Goey, O. J. L. Loosveld, Valery E.P.P. Lemmens, I. H. J. T. de Hingh, G.J.M. Creemers, F.N. van Erning
Publikováno v:
Journal of Geriatric Oncology. 4:S42
Colorectal cancer in elderly patients P039 Reduced risk of distant recurrence after adjuvant chemotherapy in elderly stage III colon cancer patients F.N. Van Erning*, G.J. Creemers, I.H.J.T. de Hingh, S.H. Goey, O.J.L. Loosveld, V.E.P.P. Lemmens. Res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fcaabbcf238cdfb547cca846b21ea91
https://doi.org/10.1016/j.jgo.2013.09.043
https://doi.org/10.1016/j.jgo.2013.09.043